Fifth Third Wealth Advisors LLC Bristol Myers Squibb CO Transaction History
Fifth Third Wealth Advisors LLC
- $2.71 Trillion
- Q3 2025
A detailed history of Fifth Third Wealth Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fifth Third Wealth Advisors LLC holds 46,987 shares of BMY stock, worth $2.04 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
46,987
Previous 42,626
10.23%
Holding current value
$2.04 Million
Previous $1.97 Billion
7.4%
% of portfolio
0.08%
Previous 0.08%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.46 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.69 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.11 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.07 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $92.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...